These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23343596)

  • 1. Personality and the acute subjective effects of d-amphetamine in humans.
    Kirkpatrick MG; Johanson CE; de Wit H
    J Psychopharmacol; 2013 Mar; 27(3):256-64. PubMed ID: 23343596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality and the subjective effects of acute amphetamine in healthy volunteers.
    White TL; Lott DC; de Wit H
    Neuropsychopharmacology; 2006 May; 31(5):1064-74. PubMed ID: 16237380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of d-amphetamine on post-error slowing in healthy volunteers.
    Wardle MC; Yang A; de Wit H
    Psychopharmacology (Berl); 2012 Mar; 220(1):109-15. PubMed ID: 21894485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective responses to amphetamine in young adults with previous mood elevation experiences.
    Schepers ST; Arndt DL; Rogers RD; Hedeker D; de Wit H
    Psychopharmacology (Berl); 2019 Nov; 236(11):3363-3370. PubMed ID: 31209507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers.
    Pester MS; Kirkpatrick MG; Geary BA; Leventhal AM
    J Psychopharmacol; 2018 Mar; 32(3):302-308. PubMed ID: 29338486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High impulsivity in rats predicts amphetamine conditioned place preference.
    Yates JR; Marusich JA; Gipson CD; Beckmann JS; Bardo MT
    Pharmacol Biochem Behav; 2012 Jan; 100(3):370-6. PubMed ID: 21807020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality and gender differences in effects of d-amphetamine on risk taking.
    White TL; Lejuez CW; de Wit H
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):599-609. PubMed ID: 18179313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.
    Kirkpatrick MG; Goldenson NI; Kapadia N; Kahler CW; de Wit H; Swift RM; McGeary JE; Sussman S; Leventhal AM
    Psychopharmacology (Berl); 2016 Jan; 233(1):89-97. PubMed ID: 26429791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet taste liking is associated with subjective response to amphetamine in women but not men.
    Weafer J; Lyon N; Hedeker D; de Wit H
    Psychopharmacology (Berl); 2017 Nov; 234(21):3185-3194. PubMed ID: 28762072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amphetamine on reactivity to emotional stimuli.
    Wardle MC; de Wit H
    Psychopharmacology (Berl); 2012 Mar; 220(1):143-53. PubMed ID: 21947316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol effects of D-amphetamine relate to traits of fearlessness and aggression but not anxiety in healthy humans.
    White TL; Grover VK; de Wit H
    Pharmacol Biochem Behav; 2006 Sep; 85(1):123-31. PubMed ID: 16934318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inattention, impulsive action, and subjective response to D-amphetamine.
    Weafer J; de Wit H
    Drug Alcohol Depend; 2013 Nov; 133(1):127-33. PubMed ID: 23790566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
    Childress AC; Brams M; Cutler AJ; Kollins SH; Northcutt J; Padilla A; Turnbow JM
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):402-14. PubMed ID: 25692608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D-amphetamine on emotion-potentiated startle in healthy humans: implications for psychopathy and antisocial behaviour.
    Corr PJ; Kumari V
    Psychopharmacology (Berl); 2013 Jan; 225(2):373-9. PubMed ID: 22864946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.
    Babcock T; Dirks B; Adeyi B; Scheckner B
    BMC Pharmacol Toxicol; 2012 Dec; 13():18. PubMed ID: 23254273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.
    Hamidovic A; Dlugos A; Skol A; Palmer AA; de Wit H
    Exp Clin Psychopharmacol; 2009 Dec; 17(6):374-83. PubMed ID: 19968402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulsiveness and subjective effects of intravenous cocaine administration in the laboratory.
    Cascella NG; Nagoshi CT; Muntaner C; Walter D; Haertzen CA; Kumor KM
    J Subst Abuse; 1994; 6(4):355-66. PubMed ID: 7780294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.